Blister test reveals sex differences in inflammation healing
NCT ID NCT05597098
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study at Queen Mary University of London aims to understand why men and women respond differently to inflammation, which may affect heart disease risk. Researchers will apply a small amount of cantharidin (a blister-inducing chemical) to the skin of 34 healthy volunteers aged 18-45. They will then compare blister size, fluid, and immune cells between sexes over 24-72 hours to see if women resolve inflammation faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cantharidin (a blister-inducing solution)
What this could lead to
If successful, this could help explain why men and women have different rates of heart disease, pointing toward sex-specific treatments for inflammation.
What could go wrong
This is a very early, small study (34 people) in healthy volunteers, not patients. It only measures blisters, not real disease outcomes, so results may not apply to actual illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The William Harvey Research Institute
RECRUITINGLondon, EC1M 6BQ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact